Description

Jacobs et al developed a Risk of Malignancy Index (RMI) for predicting the likely pathology of an ovarian or pelvic mass as benign or malignant.


 

Parameters:

(1) menopausal status

(2) ultrasound findings suggestive of malignancy

(3) serum CA125 (cancer antigen 125) in U/mL

 

Criteria for postmenopausal:

(1) amenorrhoea > 1 year, or

(2) women over 50 years of age with previous hysterectomy.

 

Ultrasound findings suggestive of malignancy:

(1) multi-loculated cysts

(2) evidence of solid areas

(3) evidence of metastases

(4) presence of ascites

(5) bilateral lesions

Parameter

Finding

Points

menopausal status

pre-menopausal

1

 

post-menopausal

3

ultrasound findings suggestive of malignancy

none

0

 

1

1

 

>= 2

3

 

risk of malignancy index =

= (points for menopausal status) * (points for ultrasound findings) * (serum CA125 in U/mL)

 

The derivation of the formula from the equation for the likelihood ratio is given in the Jacobs (1990, Appendix page 929).

 

Interpretation:

• minimum score: 0

• maximum score: > 10,000

• The performance varies with the cutoff selected.

 

Performance at difference cutoffs for the RMI

RMI cutoff

Sensitivity

Specificity

Positive PV

Negative PV

25

100, 97, 92, 97

62, 55,61, 60

48, 40, 45

97, 98

50

95, 97, 92, 94

76, 68, 73, 75

56, 49, 56

97, 97

100

85, 87, 90, 77

88, 85, 85, 90

71, 63, 73

97, 92

150

85, 81, 90, 65

94, 85, 88, 91

70, 68, 77

97, 89

200

85, 87, 87, 58

97, 89, 91, 93

75, 73, 78

96, 87

250

78, 76, 87, 54

99, 91, 93, 96

78, 77, 81

96, 86

NOTE: data for cutoffs at 75, 80 and 125 not shown.

 

Limitations:

• Morgante et al (1999) found that the RMI of Tinglustad et al (1996) gave better performance than the RMI of Jacobs et al.

• The prevalence of malignancy in the population would affect performance.

 


To read more or access our algorithms and calculators, please log in or register.